Navigation Links
Sanomedics Signs Letter of Intent to Acquire Large Sleep Disorder Service Based Operation
Date:12/12/2011

MIAMI, Dec. 12, 2011 /PRNewswire/ -- (Pink Sheets: SIMH)  In a shrewd execution of its business plan and growth strategy, Craig Sizer, Co-founder and Chairman, with Keith Houlihan, Co-founder and President of Sanomedics International Holdings Inc. www.sanomedics.com, announced the signing of a letter of intent to acquire a strategically targeted durable medical equipment (DME) provider with a platform in sleep apnea treatment services.  The targeted acquisition is accredited by the "Healthcare Quality Association." The operation with approximately $6 million in revenues and over $1 million in (EBITDA) earnings before interest, taxes, depreciation and amortization is expected to close in early 2012 upon the completion of due diligence and Sanomedics board approval.

"The acquisition of a sleep treatment service based operations is an important step in the growth of Sanomedics, as well as for the distribution and sales expansion of our ThermoMedics line of non-contact clinical thermometers," said Craig Sizer Chairman and Co-founder.

The targeted acquisition has a strong patient base and consistent growth over the last five years within the sleep disorder treatment market. It also offers a wide array of durable medical equipment and supplies and over 30 contracts with skilled nursing facilities which manages healthcare for a rapidly aging population.

"This acquisition is the first step in our strategy as a sleep medicine based business, it is a first class operation, with values that fit well with our business growth objectives," said Keith Houlihan, Co-founder and President. "As a pioneer in developing innovative health solutions, this acquisition is a bridge between the high-technology medical world and the growing home healthcare environment."

About Sanomedics             
Sanomedics International Holdings, Inc. (SIMH) manufactures and distributes innovative professional medical, as well as, home health diagnostic devices and products. As a pioneer in the trend toward preventive medicine, Sanomedics' goal is to act as a bridge between the high-technology medical world and the home healthcare environment. All Sanomedics professional and home healthcare diagnostic products are extremely easy to use, while providing accurate results in less than one second.

Forward Looking Statements
This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

©2011 Sanomedics International Holdings Inc. All rights reserved. www.sanomedics.com

 

Contact:         

Keith Houlihan

 

Co-Founder and President

 

305-433-7814


'/>"/>
SOURCE Sanomedics International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mr. Charlie Alvarez Joins the Board of Sanomedics International Holdings, Inc.
2. American Scientific Resources, Inc. Announces Dismissal of Sanomedics International Holdings, Inc. lawsuit
3. South Korea Signs Accord with Abu Dhabi Health Authority on Hospital Service Agreement
4. GeckoSystems Signs Mobile Robot Joint Venture With Chinese Wheelchair Manufacturer
5. IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
6. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
7. Bend Research Signs Technology Licensing Agreement with Merck
8. Astellas Signs United Nations Global Compact
9. Rapid Fire Marketing: Medical Cannabis Management Signs Agreement with Second Non-Profit
10. Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics
11. Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):